爱舍伦募2.7亿首日涨176% 大客户销售真实性曾被问询

Core Viewpoint - Aishalon Medical Technology Group Co., Ltd. (stock code: 920050.BJ) was listed on the Beijing Stock Exchange, opening at 48.88 yuan and closing at 44.04 yuan, with a significant increase of 175.59% and a total market capitalization of 2.981 billion yuan [1]. Company Overview - Aishalon focuses on the medical health sector, primarily engaged in the research, production, and sales of disposable medical consumables for rehabilitation care and medical protection [1]. - The company provides products to internationally renowned medical device brands through ODM/OEM methods [1]. Shareholding Structure - The controlling shareholder is Jiangsu Novick Technology Investment Co., Ltd., with Zhang Yong as the actual controller, holding a total of 88.69% of the company's shares [1][2]. - After the issuance, Zhang Yong directly holds 1,000,000 shares (1.48%) and indirectly controls 45,017,025 shares (66.52%) [2]. Financial Performance - In 2022, 2023, and 2024, Aishalon's revenue was 573.56 million yuan, 574.66 million yuan, and 691.64 million yuan, respectively, with net profits of 62.80 million yuan, 66.94 million yuan, and 80.61 million yuan [7]. - For the first half of 2025, the revenue was 438.20 million yuan, with a net profit of 49.43 million yuan [8]. - The company reported a revenue of 68.96 million yuan for the first nine months of 2025, a year-on-year increase of 42.84%, and a net profit of 7.31 million yuan, up 26.98% [11]. Fundraising and Investment Projects - Aishalon raised a total of 270.38 million yuan, with a net amount of 240.18 million yuan allocated for the construction of the Caprol Public Health Medical Supplies Industrial Park [5]. - The total investment for the Caprol project is 670.46 million yuan, with 300 million yuan funded through this issuance [6]. Future Projections - The company expects 2025 revenue to be between 889.82 million yuan and 939.87 million yuan, representing a growth of 28.65% to 35.89% compared to 2024 [12]. - The projected net profit for 2025 is estimated to be between 89.29 million yuan and 98.48 million yuan, indicating a growth of 10.63% to 22.01% [12].